000 -LEADER |
fixed length control field |
01403nam a2200241 a 4500 |
001 - CONTROL NUMBER |
control field |
vtls003026464 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
MY-SjTCS |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20200306163248.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
110218s2002 nyua b 001 0 eng |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
082470763X (hbk.) |
039 #9 - LEVEL OF BIBLIOGRAPHIC CONTROL AND CODING DETAIL [OBSOLETE] |
Level of rules in bibliographic description |
201102181511 |
Level of effort used to assign nonsubject heading access points |
VLOAD |
Level of effort used to assign subject headings |
200604171431 |
Level of effort used to assign classification |
susan |
Level of effort used to assign subject headings |
200603091258 |
Level of effort used to assign classification |
radtha |
-- |
200603091233 |
-- |
radtha |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.190727 |
Item number |
CHO |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Chow, Shein-Chung, |
Dates associated with a name |
1955- |
9 (RLIN) |
20662 |
245 10 - TITLE STATEMENT |
Title |
Statistics in drug research : |
Remainder of title |
methodologies and recent developments / |
Statement of responsibility, etc. |
Shein-Chung Chow, June Shao. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
New York : |
Name of publisher, distributor, etc. |
M. Dekker, |
Date of publication, distribution, etc. |
c2002. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xiv, 367 p. : |
Other physical details |
ill. ; |
Dimensions |
23 cm. |
440 #0 - SERIES STATEMENT/ADDED ENTRY--TITLE |
Title |
Biostatistics ; |
Volume/sequential designation |
10 |
9 (RLIN) |
230266 |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliographical references and index. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Series Introduction. - Preface. - Chapter 1. Introduction. - Chapter 2. Pharmaceutical Validation. - Chapter 3. Dissolution Testing. - Chapter 4. Stability Analysis. - Chapter 5. Bioavailability and Bioequivalence. - Chapter 6. Randomization and Blinding. - Chapter 7. Substantial Evidence in Clinical Development. - Chapter 8. Therapeutic Equivalence and Noninferiority. - Chapter 9. Analysis of Incomplete Data. - Chapter 10. Meta-Analysis. - Chapter 11. Quality of Life. - Chapter 12. Medical Imaging. - References. - Subject Index. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drugs |
General subdivision |
Research |
-- |
Statistical methods. |
9 (RLIN) |
21110 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Shao, Jun. |
Relator term |
(j.a.) |
9 (RLIN) |
230267 |
920 ## - Programme |
Programme |
BMS : 260496 |
999 ## - SYSTEM CONTROL NUMBERS (KOHA) |
Koha biblionumber |
40626 |
Koha biblioitemnumber |
40626 |